Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
Oligodendrocyte death results in immune-mediated CNS demyelination.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Biogen Idec receives negative opinion from the CHMP on Fampyra
Fingolimod Impedes Schwann Cell-Mediated Myelination: Implications for the Treatment of Immune Neuropathies?Effect of Fingolimod on Schwann Cells.
EMD Serono
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
Intermittent self-catheterisation in MS.
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
New multiple sclerosis phenotypic classification.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.

Pages